Annonce • May 18
E.I.D.- Parry (India) Limited to Report Q4, 2026 Results on May 26, 2026 E.I.D.- Parry (India) Limited announced that they will report Q4, 2026 results on May 26, 2026 Reported Earnings • Feb 14
Third quarter 2026 earnings released: EPS: ₹13.05 (vs ₹10.97 in 3Q 2025) Third quarter 2026 results: EPS: ₹13.05 (up from ₹10.97 in 3Q 2025). Revenue: ₹103.8b (up 19% from 3Q 2025). Net income: ₹2.32b (up 19% from 3Q 2025). Profit margin: 2.2% (in line with 3Q 2025). Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth. Annonce • Jan 28
E.I.D.- Parry (India) Limited to Report Q3, 2026 Results on Feb 12, 2026 E.I.D.- Parry (India) Limited announced that they will report Q3, 2026 results on Feb 12, 2026 Reported Earnings • Nov 12
Second quarter 2026 earnings released: EPS: ₹23.87 (vs ₹17.22 in 2Q 2025) Second quarter 2026 results: EPS: ₹23.87 (up from ₹17.22 in 2Q 2025). Revenue: ₹117.8b (up 26% from 2Q 2025). Net income: ₹4.24b (up 39% from 2Q 2025). Profit margin: 3.6% (up from 3.3% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings. Annonce • Oct 23
E.I.D.- Parry (India) Limited to Report Q2, 2026 Results on Nov 11, 2025 E.I.D.- Parry (India) Limited announced that they will report Q2, 2026 results on Nov 11, 2025 Annonce • Jul 16
E.I.D.- Parry (India) Limited to Report Q1, 2026 Results on Aug 06, 2025 E.I.D.- Parry (India) Limited announced that they will report Q1, 2026 results on Aug 06, 2025 New Risk • Jul 16
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company. Reported Earnings • Jul 16
Full year 2025 earnings: EPS in line with expectations, revenues disappoint Full year 2025 results: EPS: ₹49.46 (down from ₹50.68 in FY 2024). Revenue: ₹316.1b (up 7.5% from FY 2024). Net income: ₹8.78b (down 2.4% from FY 2024). Profit margin: 2.8% (down from 3.1% in FY 2024). Revenue missed analyst estimates by 4.6%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 9.6% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings. Price Target Changed • Jun 03
Price target increased by 17% to ₹1,105 Up from ₹945, the current price target is provided by 1 analyst. New target price is 12% above last closing price of ₹984. Stock is up 52% over the past year. The company is forecast to post earnings per share of ₹60.50 for next year compared to ₹49.47 last year. Board Change • Jun 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 7 experienced directors. 1 highly experienced director. Non-Executive Independent Director Meghna Apparao was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • May 28
Full year 2025 earnings: EPS in line with expectations, revenues disappoint Full year 2025 results: EPS: ₹49.47 (down from ₹50.68 in FY 2024). Revenue: ₹319.7b (up 8.7% from FY 2024). Net income: ₹8.78b (down 2.4% from FY 2024). Profit margin: 2.7% (down from 3.1% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.6%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 9.1% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings. Annonce • May 27
E.I.D.- Parry (India) Limited, Annual General Meeting, Aug 06, 2025 E.I.D.- Parry (India) Limited, Annual General Meeting, Aug 06, 2025. Annonce • May 13
E.I.D.- Parry (India) Limited to Report Q4, 2025 Results on May 27, 2025 E.I.D.- Parry (India) Limited announced that they will report Q4, 2025 results at 12:08 PM, Indian Standard Time on May 27, 2025 Major Estimate Revision • Feb 18
Consensus EPS estimates fall by 26% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₹65.90 to ₹49.00 per share. Revenue forecast steady at ₹331.4b. Net income forecast to grow 32% next year vs 29% growth forecast for Chemicals industry in India. Consensus price target down from ₹1,000 to ₹945. Share price fell 8.7% to ₹719 over the past week. Reported Earnings • Feb 12
Third quarter 2025 earnings released: EPS: ₹10.97 (vs ₹6.66 in 3Q 2024) Third quarter 2025 results: EPS: ₹10.97 (up from ₹6.66 in 3Q 2024). Revenue: ₹88.4b (up 14% from 3Q 2024). Net income: ₹1.95b (up 65% from 3Q 2024). Profit margin: 2.2% (up from 1.5% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings. Annonce • Jan 29
E.I.D.- Parry (India) Limited to Report Q3, 2025 Results on Feb 11, 2025 E.I.D.- Parry (India) Limited announced that they will report Q3, 2025 results on Feb 11, 2025 Price Target Changed • Jan 24
Price target increased by 12% to ₹1,000 Up from ₹890, the current price target is provided by 1 analyst. New target price is 22% above last closing price of ₹820. Stock is up 33% over the past year. The company is forecast to post earnings per share of ₹65.90 for next year compared to ₹50.68 last year. Annonce • Jan 02
E.I.D.- Parry (India) Limited Announces Retirement of T. Kannan as Senior Vice President - Commercial E.I.D.- Parry (India) Limited announced that the following Senior Management Personnel of the Company will retire from their position effective close of business hours on December 31, 2024. Mr. T. Kannan, Senior Vice President - Commercial and Mr. V. Vasudevan, Vice President - IT. Please take the above information on record. Reported Earnings • Nov 16
Second quarter 2025 earnings released: EPS: ₹17.22 (vs ₹25.48 in 2Q 2024) Second quarter 2025 results: EPS: ₹17.22 (down from ₹25.48 in 2Q 2024). Revenue: ₹94.0b (up 3.8% from 2Q 2024). Net income: ₹3.06b (down 32% from 2Q 2024). Profit margin: 3.3% (down from 5.0% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth. Annonce • Nov 14
E.I.D.- Parry (India) Limited Appoints Mr. V R Chandrasekar to Head the IT Function E.I.D.- Parry (India) Limited announced that the appointment of Mr. V R Chandrasekar to head the IT function. Mr. V R Chandrasekar is a qualified Chartered Accountant and Post graduate in Al for Leaders from Great Lakes. He has 26+ years of diverse and multi-disciplinary experience in strategizing, consulting and execution of transformation projects across enterprise processes and across geographies. Annonce • Oct 31
E.I.D.- Parry (India) Limited to Report Q2, 2025 Results on Nov 14, 2024 E.I.D.- Parry (India) Limited announced that they will report Q2, 2025 results on Nov 14, 2024 Annonce • Aug 19
E.I.D.- Parry (India) Limited Announces Retirement of S. Suresh as Managing Director E.I.D.- Parry (India) Limited informed that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors at their meeting held August 17, 2024, have approved the early retirement of Mr. S. Suresh as Managing Director of the Company with effect from the closing the business hours of August 31, 2024. Consequent to the early retirement of Mr. S. Suresh, Mr. Muthiah Murugappan, Whole-Time Director and Chief Executive Officer will be a Key Managerial Personnel (KM P) of the Company with effect from September 1, 2024. Annonce • Aug 02
E.I.D.- Parry (India) Limited to Report Q1, 2025 Results on Aug 14, 2024 E.I.D.- Parry (India) Limited announced that they will report Q1, 2025 results on Aug 14, 2024 Reported Earnings • Jul 25
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: ₹50.68 (down from ₹53.39 in FY 2023). Revenue: ₹294.1b (down 17% from FY 2023). Net income: ₹9.00b (down 5.0% from FY 2023). Profit margin: 3.1% (up from 2.7% in FY 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 36%. Revenue is expected to decline by 110% p.a. on average during the next 2 years, while revenues in the Chemicals industry in India are expected to grow by 11%. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 21% per year. Price Target Changed • Jun 20
Price target increased by 20% to ₹890 Up from ₹741, the current price target is provided by 1 analyst. New target price is 11% above last closing price of ₹803. Stock is up 66% over the past year. The company is forecast to post earnings per share of ₹19.40 for next year compared to ₹50.68 last year. Annonce • May 26
E.I.D.- Parry (India) Limited, Annual General Meeting, Aug 14, 2024 E.I.D.- Parry (India) Limited, Annual General Meeting, Aug 14, 2024. Reported Earnings • May 25
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: ₹50.68 (down from ₹53.39 in FY 2023). Revenue: ₹297.2b (down 16% from FY 2023). Net income: ₹9.00b (down 5.0% from FY 2023). Profit margin: 3.0% (up from 2.7% in FY 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 36%. Revenue is expected to decline by 111% p.a. on average during the next 2 years, while revenues in the Chemicals industry in India are expected to grow by 12%. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 15% per year. Annonce • May 25
E.I.D.- Parry (India) Limited Appoints Abdul Hakeem Ashiq J as Chief Operating Officer, Effective May 27, 2024 E.I.D.- Parry (India) Limited at its board meeting held on May 24, 2024, based on the recommendations of the Nomination and Remuneration Committee, at their meeting held prior to the Board Meeting, the Board has approved the appointment of Abdul Hakeem Ashiq J as a Chief Operating Officer of the Company with effect from May 27, 2024. Mr. Abdul Hakeem Ashiq J, aged 50 years, holds a Bachelor's degree in Chemical Engineering from Anna University and Master of Management from School of Management I.I.T Mumbai. He has more than two decades of rich experience spanning across Sales & Marketing, Strategic Revenue Management, People management, Operations & Manufacturing and P&L Delivery in both regional and national roles. Annonce • May 17
E.I.D.- Parry (India) Limited to Report Q4, 2024 Results on May 24, 2024 E.I.D.- Parry (India) Limited announced that they will report Q4, 2024 results on May 24, 2024 New Risk • Feb 09
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 21% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 21% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Feb 07
Third quarter 2024 earnings released: EPS: ₹6.66 (vs ₹14.14 in 3Q 2023) Third quarter 2024 results: EPS: ₹6.66 (down from ₹14.14 in 3Q 2023). Revenue: ₹78.1b (down 21% from 3Q 2023). Net income: ₹1.18b (down 53% from 3Q 2023). Profit margin: 1.5% (down from 2.5% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 22% per year. Annonce • Jan 27
E.I.D.- Parry (India) Limited to Report Q3, 2024 Results on Feb 06, 2024 E.I.D.- Parry (India) Limited announced that they will report Q3, 2024 results on Feb 06, 2024 Upcoming Dividend • Nov 14
Upcoming dividend of ₹4.00 per share at 1.6% yield Eligible shareholders must have bought the stock before 21 November 2023. Payment date: 08 December 2023. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 1.6%. Within top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.8%). New Risk • Nov 09
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 65% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 65% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Nov 09
Second quarter 2024 earnings released: EPS: ₹25.48 (vs ₹13.60 in 2Q 2023) Second quarter 2024 results: EPS: ₹25.48 (up from ₹13.60 in 2Q 2023). Revenue: ₹92.1b (down 19% from 2Q 2023). Net income: ₹4.52b (up 87% from 2Q 2023). Profit margin: 4.9% (up from 2.1% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is expected to decline by 133% p.a. on average during the next 2 years, while revenues in the Chemicals industry in India are expected to grow by 11%. Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 20% per year. Annonce • Nov 09
E.I.D.- Parry (India) Limited Approves Interim Dividend for the Financial Year 2023-24, Payable on or After December 1, 2023 The Board of E.I.D.- Parry (India) Limited approved the payment of Interim Dividend for the financial year 2023-24 at INR 4/- (Rupees Four only) per share, representing 400%, on the equity share of face value of Re.1/- each fully paid. The Record Date for the purpose of payment of Interim Dividend shall be November 21, 2023. The Interim Dividend will be paid on or after December 1, 2023, but within 30 days from date of declaration of Interim Dividend, as provided under the Companies Act,2013. Annonce • Oct 28
E.I.D.- Parry (India) Limited to Report Q2, 2024 Results on Nov 08, 2023 E.I.D.- Parry (India) Limited announced that they will report Q2, 2024 results on Nov 08, 2023 New Risk • Aug 13
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 48% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 48% per year for the foreseeable future. Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.2% net profit margin). Annonce • Aug 10
E.I.D.- Parry (India) Limited Announces Chief Financial Officer Changes The board of directors of E.I.D.- Parry (India) Limited at its meeting held on August 09, 2023, Mr. A Sridhar, Chief Financial Officer, will be stepping down as the Chief Financial Officer of the Company with effect from the close of business hours on August 31, 2023. He will continue to be associated with the company in various strategic initiatives. Based on the recommendations of the Audit Committee and Nomination and Remuneration Committee, at their meeting held prior to the Board Meeting, the Board has approved the appointment of Mr. Y. Venkateshwarlu, who is currently designated as the Senior Associate Vice President - Finance as the Chief Financial Officer of the Company with effect from September 1, 2023. Mr. Y. Venkateshwarlu is a Chartered Accountant by qualification. He has over 23 years of experience in multiple organizations in several areas including Financial Accounting & Reporting, Taxation, Treasury, financial planning, budgeting and Governance & compliance. He has expertise in Working Capital Management, Business Forecasting & Financial Modelling, debt rationalization, designing and implementation of Systems, policies & Procedures. His previous assignments were in Initial Public Offerings, financial analysis such as budget setting, expense variance analysis & Financial consolidation, tracking of potential project revenue leakage, Indian tax compliance and submissions covering corporate tax, service tax and withholding taxes including tax returns, internal reporting and tax accounting. His previous assignments were with Shree Renuka Sugars Limited between 2018-2022, United Spirits Limited, Bangalore between 2006-18, Nicholas Piramal between 2005-06 and with SMS Pharmaceuticals Ltd. between 2001-05. Annonce • Jul 25
E.I.D.- Parry (India) Limited to Report Q1, 2024 Results on Aug 09, 2023 E.I.D.- Parry (India) Limited announced that they will report Q1, 2024 results on Aug 09, 2023 Reported Earnings • Jul 17
Full year 2023 earnings released: EPS: ₹53.39 (vs ₹51.17 in FY 2022) Full year 2023 results: EPS: ₹53.39 (up from ₹51.17 in FY 2022). Revenue: ₹352.4b (up 50% from FY 2022). Net income: ₹9.47b (up 4.5% from FY 2022). Profit margin: 2.7% (down from 3.9% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 117% p.a. on average during the next 2 years, while revenues in the Chemicals industry in India are expected to grow by 10.0%. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 31
Full year 2023 earnings released: EPS: ₹53.39 (vs ₹51.17 in FY 2022) Full year 2023 results: EPS: ₹53.39 (up from ₹51.17 in FY 2022). Revenue: ₹352.8b (up 50% from FY 2022). Net income: ₹9.47b (up 4.5% from FY 2022). Profit margin: 2.7% (down from 3.9% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 32% per year. Upcoming Dividend • Apr 14
Upcoming dividend of ₹4.00 per share at 1.6% yield Eligible shareholders must have bought the stock before 21 April 2023. Payment date: 10 May 2023. Payout ratio is a comfortable 9.1% and the cash payout ratio is 87%. Trailing yield: 1.6%. Lower than top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (0.8%). Reported Earnings • Feb 15
Third quarter 2023 earnings released: EPS: ₹14.14 (vs ₹12.85 in 3Q 2022) Third quarter 2023 results: EPS: ₹14.14 (up from ₹12.85 in 3Q 2022). Revenue: ₹98.6b (up 51% from 3Q 2022). Net income: ₹2.51b (up 10% from 3Q 2022). Profit margin: 2.5% (down from 3.5% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth. Annonce • Feb 04
E.I.D.- Parry (India) Limited to Report Q3, 2023 Results on Feb 14, 2023 E.I.D.- Parry (India) Limited announced that they will report Q3, 2023 results on Feb 14, 2023 Reported Earnings • Nov 16
Second quarter 2023 earnings released: EPS: ₹13.60 (vs ₹13.77 in 2Q 2022) Second quarter 2023 results: EPS: ₹13.60 (down from ₹13.77 in 2Q 2022). Revenue: ₹113.3b (up 62% from 2Q 2022). Net income: ₹2.41b (down 1.0% from 2Q 2022). Profit margin: 2.1% (down from 3.5% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 5.9% p.a. on average during the next 2 years, while revenues in the Chemicals industry in India are expected to grow by 12%. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Nov 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Additional Non-Executive Independent Director Meghna Apparao was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 13
Second quarter 2023 earnings released: EPS: ₹13.60 (vs ₹13.77 in 2Q 2022) Second quarter 2023 results: EPS: ₹13.60 (down from ₹13.77 in 2Q 2022). Revenue: ₹113.6b (up 63% from 2Q 2022). Net income: ₹2.41b (down 1.0% from 2Q 2022). Profit margin: 2.1% (down from 3.5% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 5.9% p.a. on average during the next 2 years, while revenues in the Chemicals industry in India are expected to grow by 12%. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Aug 02
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Additional Non-Executive Independent Director Meghna Apparao was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jul 19
Full year 2022 earnings: Revenues exceed analyst expectations Full year 2022 results: Revenue: ₹235.3b (flat on FY 2021). Net income: ₹9.07b (up 103% from FY 2021). Profit margin: 3.9% (up from null in FY 2021). Revenue exceeded analyst estimates by 2.2%. Over the next year, revenue is forecast to grow 16%, compared to a 17% growth forecast for the industry in India. Valuation Update With 7 Day Price Move • May 31
Investor sentiment improved over the past week After last week's 16% share price gain to ₹556, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 202% over the past three years. Reported Earnings • May 19
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2022 results: EPS: ₹51.17 (up from ₹25.27 in FY 2021). Revenue: ₹237.4b (up 28% from FY 2021). Net income: ₹9.07b (up 103% from FY 2021). Profit margin: 3.8% (up from 2.4% in FY 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 5.5%. Over the next year, revenue is forecast to grow 15%, compared to a 21% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Apr 27
Price target increased to ₹585 Up from ₹526, the current price target is provided by 1 analyst. New target price is 12% above last closing price of ₹522. Stock is up 63% over the past year. The company is forecast to post earnings per share of ₹54.00 for next year compared to ₹25.27 last year. Price Target Changed • Mar 16
Price target increased to ₹585 Up from ₹526, the current price target is provided by 1 analyst. New target price is 37% above last closing price of ₹427. Stock is up 25% over the past year. The company is forecast to post earnings per share of ₹54.00 for next year compared to ₹25.27 last year. Upcoming Dividend • Mar 03
Upcoming dividend of ₹5.50 per share Eligible shareholders must have bought the stock before 10 March 2022. Payment date: 30 March 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.7%. Within top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.8%). Reported Earnings • Feb 10
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2022 results: EPS: ₹12.85 (up from ₹6.02 in 3Q 2021). Revenue: ₹65.3b (up 39% from 3Q 2021). Net income: ₹2.28b (up 114% from 3Q 2021). Profit margin: 3.5% (up from 2.3% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 13%. Earnings per share (EPS) missed analyst estimates by 38%. Over the next year, revenue is forecast to grow 14%, compared to a 20% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 34% per year whereas the company’s share price has increased by 35% per year. Recent Insider Transactions • Nov 18
MD & Executive Non-Independent Director recently sold ₹18m worth of stock On the 15th of November, S. Suresh sold around 36k shares on-market at roughly ₹508 per share. This was the largest sale by an insider in the last 3 months. This was S.'s only on-market trade for the last 12 months. Reported Earnings • Nov 10
Second quarter 2022 earnings released: EPS ₹13.77 (vs ₹17.95 in 2Q 2021) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹70.0b (up 20% from 2Q 2021). Net income: ₹2.44b (down 23% from 2Q 2021). Profit margin: 3.5% (down from 5.4% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 13
First quarter 2022 earnings released: EPS ₹7.49 (vs ₹1.66 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹44.1b (up 6.5% from 1Q 2021). Net income: ₹1.33b (up 352% from 1Q 2021). Profit margin: 3.0% (up from 0.7% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Executive Departure • Aug 13
Senior VP & CFO S. Kumar has left the company During their tenure, earnings grew by 545% annually compared to the industry average of 39%. On the 12th of August, S. Kumar left the company after 2.6 in the role. We don't have any record of a personal shareholding under Kumar's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 4.00 years. Reported Earnings • Jul 03
Full year 2021 earnings released: EPS ₹25.27 (vs ₹26.43 in FY 2020) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: ₹185.9b (up 8.5% from FY 2020). Net income: ₹4.47b (down 4.4% from FY 2020). Profit margin: 2.4% (down from 2.7% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Price Target Changed • Jul 03
Price target increased to ₹539 Up from ₹489, the current price target is provided by 1 analyst. New target price is 29% above last closing price of ₹417. Stock is up 58% over the past year. Valuation Update With 7 Day Price Move • May 04
Investor sentiment improved over the past week After last week's 21% share price gain to ₹388, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 48% over the past three years. Price Target Changed • Feb 21
Price target raised to ₹514 Up from ₹410, the current price target is an average from 2 analysts. The new target price is 61% above the current share price of ₹319. As of last close, the stock is up 55% over the past year. Executive Departure • Feb 16
Non Executive Independent Director has left the company On the 7th of February, Chinni Ranganathan's tenure as Non Executive Independent Director ended after 3.3 years in the role. We don't have any record of a personal shareholding under Chinni's name. Chinni is the only executive to leave the company over the last 12 months. 